Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04790409
Status:
COMPLETED
Last Update Posted:
2023-09-14
First Post:
2021-02-18
Brief Title:
Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-18
First Submit QC Date:
March 9 2021
Study First Post Date:
2021-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-13
Last Update Post Date:
2023-09-14
Last Update Post Date Type:
ACTUAL